Share it: Subscribe
DistilNFO M & A
Life Sciences M&A Advisory

Weekly Top 10 News
Mon, 29 Oct 2018
M&A Perspectives
1. Trump outlines new plan to lower Medicare drug prices, end ‘rigged’ system
2. Amazon will sell an exclusive brand of home health products called Choice, made by Arcadia Group
New M & A Activity
3. Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD
4. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
5. Pyramidion Technology Group, Inc. (“PYTG”) Announces Closing Its Acquisition With Established CBD Company NxGen Brands, LLC
6. Riverchase Dermatology and Cosmetic Surgery Acquires Wittenborn Plastic Surgery and Welcomes William S. Wittenborn, M.D.
7. Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery
8. Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd.
9. Athenahealth fields multiple bids, but offers not much higher than current stock price
10. Resonetics Announces Acquisition Of STI Laser Industries
11. NeoGenomics Reports Acquisition of Genoptix for $125M in Cash & 1M Common Shares
12. Therapix Biosciences up 72% premarket on bid from FSD Pharma
13. Navigation Sciences Acquires Exclusive Rights to Novel Technology for Minimally-Invasive, Lung Cancer and Other Soft Tissue Procedures
14. Keeping up deal frenzy, Alexion strikes an RNAi pact
15. Cedar Gate Technologies Acquires Prospective Bundled Payment Technology Company
16. Two Labs Acquires Pennside Partners Ltd.
17. Clearlake Capital to acquire SYMPLR
18. CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited
19. Evergreen Pacific Insurance Corporation Closes Acquisition of Majority Interest in Synergy Health Services
20. Protect Pharmaceutical Corporation Acquires Tobit Clicks
21. Atar Capital Acquires Pathways, A Leading Behavioral Health Services Provider, From Molina Healthcare, Inc.
22. Purdue Pharma L.P. Enters into Exclusive Option Agreement to Acquire SpineThera, Inc. and Its Non- Opioid Product in Development for Epidural Steroid Injection for the Treatment of Low Back Pain
23. CoreLogic to Acquire Symbility Solutions Inc.
Other Corporate Development News
24. AbbVie, Amgen reach a deal on Humira biosimilar
25. Canopy Growth issues shares to acquire stake in Manitoba retail business
26. AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncology
27. Fresenius Helios closes acquisition of Quirónsalud
28. Cynosure Acquires Palomar Medical Technologies
29. Takeda signs $50m deal with French biotech Enterome
30. Takeda Pharmaceutical : Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc
About Ed Francis
DistilNFO's Executive Editor & Senior Industry Strategist.
Ed is the National Life Sciences Practice lead for West Monroe Partners & has more than 25 years of management consulting experience guiding some of the industry’s most prominent organizations.

If you need help with your complex transformation whether it be M&A, digital, strategic cost takeout Ed can be contacted at efrancis@wmp.com and +1-847-910-6073

Or connect with him at

Advertise with us

We Reach Quarter Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us


5760 Legacy Dr,
ste B3-405,
Plano TX 75024
+1 469-270-3311

About DistilNFO Newsletter

We pick up top 10 news from industries relevent to you and send out the headlines weekly thus saving your time and keeping you up to date on your interest areas.

SUBSCRIBE TO NEWSLETTER
OUR WEBSITE

You are receiving this newsletter because you are subscribed to one or more DistilNFO Publications Newsletter/s. If you feel this email was sent by mistake, you can unsubscribe or update your subscription.

View in browser | Update Subscription | Advertise | Contact Us